November 30, 2007 - Volume 21 - Issue 18
pp: N3,2369-2567



Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults

Lesprit, Philippe; Pédrono, Gaëlle; Molina, Jean-Michel; More

AIDS . 21(18):2425-2434, November 30, 2007.


Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

Wand, Handan; Calmy, Alexandra; Carey, Dianne L; More

AIDS . 21(18):2445-2453, November 30, 2007.

Successful simplification of protease inhibitor-based HAART with triple nucleoside regimens in children vertically infected with HIV

Palma, Paolo; Romiti, Maria Luisa; Cancrini, Caterina; More

AIDS . 21(18):2465-2472, November 30, 2007.

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV

McComsey, Grace A; Kendall, Michelle A; Tebas, Pablo; More

AIDS . 21(18):2473-2482, November 30, 2007.


Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

Moh, Raoul; Danel, Christine; Messou, Eugène; More

AIDS . 21(18):2483-2491, November 30, 2007.

High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients

Masciotra, Silvina; Garrido, Carolina; Youngpairoj, Ae S; More

AIDS . 21(18):2503-2511, November 30, 2007.

Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART

Muga, Roberto; Ferreros, Inmaculada; Langohr, Klaus; More

AIDS . 21(18):2521-2527, November 30, 2007.

Concise Communication



Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus

Lacombe, Karine; Boyd, Anders; Desvarieux, Moise; More

AIDS . 21(18):2546-2549, November 30, 2007.



1 2 3 4 5